These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 347866)

  • 1. [Cholesterolic gallstones. Pathophysiology and treatment (author's transl)].
    Heller F; Harvengt C
    Acta Gastroenterol Belg; 1977; 40(11-12):392-405. PubMed ID: 347866
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of chenodeoxycholic acid and phenobarbital on the rate-limiting enzymes of hepatic cholesterol and bile acid synthesis in patients with gallstones.
    Coyne MJ; Bonorris GG; Goldstein LI; Schoenfield LJ
    J Lab Clin Med; 1976 Feb; 87(2):281-91. PubMed ID: 1245792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The dissolving of cholesterol gallstones. A current therapeutic problem].
    Erb W
    Med Klin; 1975 Jul; 70(28-29):1199-1207. PubMed ID: 1101004
    [No Abstract]   [Full Text] [Related]  

  • 4. [Influence of chenodeoxycholic acid on the metabolism of cholesterol and bile acids in the course of cholesterol gallstone formation in squirrel monkeys (author's transl)].
    Noshi H; Tsujii T; Fukui H; Matsui T; Nishimura Y; Tamura M
    Nihon Shokakibyo Gakkai Zasshi; 1978 Mar; 75(3):350-8. PubMed ID: 96290
    [No Abstract]   [Full Text] [Related]  

  • 5. Current status of chenodeoxycholic acid (chenodiol) therapy of cholesterol gallstones.
    Zak RA; Marks JW; Schoenfield LJ
    Semin Liver Dis; 1983 May; 3(2):132-45. PubMed ID: 6408740
    [No Abstract]   [Full Text] [Related]  

  • 6. Biliary lipid synthesis and secretion in gallstone patients before and during treatment with chenodeoxycholic acid.
    Key PH; Bonorris GG; Marks JW; Chung A; Schoenfield LJ
    J Lab Clin Med; 1980 Jun; 95(6):816-26. PubMed ID: 7381293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Part II. The systemic treatment of gallstones.
    Tompkins RK
    Adv Surg; 1976; 10():87-98. PubMed ID: 824939
    [No Abstract]   [Full Text] [Related]  

  • 8. Chenodeoxycholic acid: uses and limitations.
    Schoenfield LJ
    Hosp Pract; 1979 Oct; 14(10):57-65. PubMed ID: 478496
    [No Abstract]   [Full Text] [Related]  

  • 9. Ursodeoxycholic acid versus chenodeoxycholic acid. Comparison of their effects on bile acid and bile lipid composition in patients with cholesterol gallstones.
    Stiehl A; Czygan P; Kommerell B; Weis HJ; Holtermüller KH
    Gastroenterology; 1978 Dec; 75(6):1016-20. PubMed ID: 30674
    [No Abstract]   [Full Text] [Related]  

  • 10. Gallstone formation and dissolution.
    Morrissey KP
    Major Probl Clin Surg; 1982; 16():61-100. PubMed ID: 7054618
    [No Abstract]   [Full Text] [Related]  

  • 11. Gallstone formation and dissolution.
    Coyne MJ; Schoenfield LJ
    Prog Liver Dis; 1976; 5():622-35. PubMed ID: 775559
    [No Abstract]   [Full Text] [Related]  

  • 12. Bile acid synthesis.
    Salen G; Shefer S
    Annu Rev Physiol; 1983; 45():679-85. PubMed ID: 6847167
    [No Abstract]   [Full Text] [Related]  

  • 13. Mechanism of cholesterol gallstones formation.
    Grundy SM
    Semin Liver Dis; 1983 May; 3(2):97-111. PubMed ID: 6683429
    [No Abstract]   [Full Text] [Related]  

  • 14. [Medical treatment of cholesterol cholelithiasis using chemodeoxycholic acid in man].
    Barbara L; Roda E; Roda A; Casanova S; Festi D; Sama C; Mazella G; Aldini R
    Minerva Med; 1977 Oct; 68(49):3355-82. PubMed ID: 927713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Dissolution of cholesterol gallstones with chenodeoxycholic acid (author's transl)].
    Paumgartner G
    Ther Umsch; 1977 Nov; 34(11):767-71. PubMed ID: 412270
    [No Abstract]   [Full Text] [Related]  

  • 16. Lipid metabolism and the enterohepatic circulation: the regulatory functions of HMG CoA reductase and cholesterol 7 alpha hydroxylase.
    Shepherd J; Packard CJ
    Adv Exp Med Biol; 1987; 210():117-22. PubMed ID: 3591543
    [No Abstract]   [Full Text] [Related]  

  • 17. [Pathophysiological aspects of cholelithiasis].
    Paumgartner G
    Z Gastroenterol Verh; 1976; (9):16-9. PubMed ID: 64077
    [No Abstract]   [Full Text] [Related]  

  • 18. Pathogenesis and therapy of cholesterol gallstones: with emphasis on the metabolic effects of chenodeoxycholic acid.
    Conley DR; Goldstein LI
    Med Clin North Am; 1975 Jul; 59(4):1025-33. PubMed ID: 1142861
    [No Abstract]   [Full Text] [Related]  

  • 19. [Symposium on pathophysiology of biliary tract diseases with special emphasis on gallstone disease. (6) Basic and clinical studies on bile acid preparations for the treatment of gallstones (author's transl)].
    Kajiyama G; Maruhashi A
    Nihon Naika Gakkai Zasshi; 1977 Sep; 66(9):1201-5. PubMed ID: 591759
    [No Abstract]   [Full Text] [Related]  

  • 20. [The problem of gallstone dissolution (author's transl)].
    Holub K
    Zentralbl Chir; 1977; 102(14):833-8. PubMed ID: 333824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.